Lol, I'm thinking they've got enough on their plate already, without going and looking for more contracts in the short term. Plenty to deliver over the next year or so.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025